Skip to main content
Erschienen in: Surgical Endoscopy 6/2019

24.09.2018

Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon’s experience

verfasst von: Luca Morelli, Gregorio Di Franco, Valentina Lorenzoni, Simone Guadagni, Matteo Palmeri, Niccolò Furbetta, Desirée Gianardi, Matteo Bianchini, Giovanni Caprili, Franco Mosca, Giuseppe Turchetti, Alfred Cuschieri

Erschienen in: Surgical Endoscopy | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Robotic-assisted surgery by the da Vinci Si appears to benefit rectal cancer surgery in selected patients, but still has some limitations, one of which is its high costs. Preliminary studies have indicated that the use of the new da Vinci Xi provides some added advantages, but their impact on cost is unknown. The aim of the present study is to compare surgical outcomes and costs of rectal cancer resection by the two platforms, in a single surgeon’s experience.

Methods

From April 2010 to April 2017, 90 robotic rectal resections were performed, with either the da Vinci Si (Si-RobTME) or the da Vinci Xi (Xi-RobTME). Based on CUSUM analysis, two comparable groups of 40 consecutive Si-RobTME and 40 consecutive Xi-RobTME were obtained from the prospectively collected database and used for the present retrospective comparative study. Data costs were analysed based on the level of experience on the proficiency–gain curve (p–g curve) by the surgeon with each platform.

Results

In both groups, two homogeneous phases of the p–g curve were identified: Si1 and Xi1: cases 1–19, Si2 and Xi2: cases 20–40. A significantly higher number of full RAS operations were achieved in the Xi-RobTME group (p < 0.001). A statistically significant reduction in operating time (OT) during Si2 and Xi2 phase was observed (p < 0.001), accompanied by reduced overall variable costs (OVC), personnel costs (PC) and consumable costs (CC) (p < 0.001). All costs were lower in the Xi2 phase compared to Si2 phase: OT 265 versus 290 min (p = 0.052); OVC 7983 versus 10231.9 (p = 0.009); PC 1151.6 versus 1260.2 (p = 0.052), CC 3464.4 versus 3869.7 (p < 0.001).

Conclusions

Our experience confirms a significant reduction of costs with increasing surgeon’s experience with both platforms. However, the economic gain was higher with the Xi with shorter OT, reduced PC and CC, in addition to a significantly larger number of cases performed by the fully robotic approach.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Morelli L, Ceccarelli C, Di Franco G, Guadagni S, Palmeri M, Caprili G, D’Isidoro C, Marciano E, Pollina L, Campani D, Massimetti G, Di Candio G, Mosca F (2016) Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer. Int J Colorectal Dis 31:913–915. https://doi.org/10.1007/s00384-015-2301-z CrossRefPubMed Morelli L, Ceccarelli C, Di Franco G, Guadagni S, Palmeri M, Caprili G, D’Isidoro C, Marciano E, Pollina L, Campani D, Massimetti G, Di Candio G, Mosca F (2016) Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer. Int J Colorectal Dis 31:913–915. https://​doi.​org/​10.​1007/​s00384-015-2301-z CrossRefPubMed
6.
Zurück zum Zitat Young M, Pigazzi A (2014) Total mesorectal excision: open, laparoscopic or robotic. In: Recent results cancer research, pp 47–55 Young M, Pigazzi A (2014) Total mesorectal excision: open, laparoscopic or robotic. In: Recent results cancer research, pp 47–55
9.
Zurück zum Zitat Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi P, Edlin R, Hulme C, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR Randomized Clinical Trial. JAMA 318:1569. https://doi.org/10.1001/jama.2017.7219 CrossRefPubMedPubMedCentral Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi P, Edlin R, Hulme C, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR Randomized Clinical Trial. JAMA 318:1569. https://​doi.​org/​10.​1001/​jama.​2017.​7219 CrossRefPubMedPubMedCentral
12.
15.
Zurück zum Zitat Ozben V, Cengiz TB, Atasoy D, Bayraktar O, Aghayeva A, Erguner I, Baca B, Hamzaoglu I, Karahasanoglu T (2016) Is da Vinci Xi Better than da Vinci Si in robotic rectal cancer surgery? Comparison of the 2 generations of da Vinci systems. Surg Laparosc Endosc Percutaneous Tech 26:417–423. https://doi.org/10.1097/SLE.0000000000000320 CrossRef Ozben V, Cengiz TB, Atasoy D, Bayraktar O, Aghayeva A, Erguner I, Baca B, Hamzaoglu I, Karahasanoglu T (2016) Is da Vinci Xi Better than da Vinci Si in robotic rectal cancer surgery? Comparison of the 2 generations of da Vinci systems. Surg Laparosc Endosc Percutaneous Tech 26:417–423. https://​doi.​org/​10.​1097/​SLE.​0000000000000320​ CrossRef
16.
Zurück zum Zitat Morelli L, Guadagni S, Di Franco G, Palmeri M, Caprili G, D’Isidoro C, Pisano R, Moglia A, Ferrari V, Di Candio G, Mosca F (2015) Use of the new Da Vinci Xi during robotic rectal resection for cancer: technical considerations and early experience. Int J Colorectal Dis 30:1281–1283. https://doi.org/10.1007/s00384-015-2350-3 CrossRef Morelli L, Guadagni S, Di Franco G, Palmeri M, Caprili G, D’Isidoro C, Pisano R, Moglia A, Ferrari V, Di Candio G, Mosca F (2015) Use of the new Da Vinci Xi during robotic rectal resection for cancer: technical considerations and early experience. Int J Colorectal Dis 30:1281–1283. https://​doi.​org/​10.​1007/​s00384-015-2350-3 CrossRef
17.
Zurück zum Zitat Morelli L, Guadagni S, Di Franco G, Palmeri M, Caprili G, D’Isidoro C, Cobuccio L, Marciano E, Di Candio G, Mosca F (2017) Use of the new da Vinci Xi® during robotic rectal resection for cancer: a pilot matched-case comparison with the da Vinci Si®. Int J Med Robot Comput Assist Surg 13:e1728. https://doi.org/10.1002/rcs.1728 CrossRef Morelli L, Guadagni S, Di Franco G, Palmeri M, Caprili G, D’Isidoro C, Cobuccio L, Marciano E, Di Candio G, Mosca F (2017) Use of the new da Vinci Xi® during robotic rectal resection for cancer: a pilot matched-case comparison with the da Vinci Si®. Int J Med Robot Comput Assist Surg 13:e1728. https://​doi.​org/​10.​1002/​rcs.​1728 CrossRef
18.
Zurück zum Zitat Morelli L, Di Franco G, Guadagni S, Rossi L, Palmeri M, Furbetta N, Gianardi D, Bianchini M, Caprili G, D’Isidoro C, Mosca F, Moglia A, Cuschieri A (2018) Robot-assisted total mesorectal excision for rectal cancer: case-matched comparison of short-term surgical and functional outcomes between the da Vinci Xi and Si. Surg Endosc 32:589–600. https://doi.org/10.1007/s00464-017-5708-5 CrossRefPubMed Morelli L, Di Franco G, Guadagni S, Rossi L, Palmeri M, Furbetta N, Gianardi D, Bianchini M, Caprili G, D’Isidoro C, Mosca F, Moglia A, Cuschieri A (2018) Robot-assisted total mesorectal excision for rectal cancer: case-matched comparison of short-term surgical and functional outcomes between the da Vinci Xi and Si. Surg Endosc 32:589–600. https://​doi.​org/​10.​1007/​s00464-017-5708-5 CrossRefPubMed
20.
Zurück zum Zitat Palmeri M, Gianardi D, Guadagni S, Di Franco G, Bastiani L, Furbetta N, Simoncini T, Zirafa C, Melfi F, Buccianti P, Moglia A, Cuschieri A, Mosca F, Morelli L (2018) Robotic colorectal resection with and without the use of the new Da Vinci table motion: a case-matched study. Surg Innov. https://doi.org/10.1177/1553350618765540 CrossRefPubMed Palmeri M, Gianardi D, Guadagni S, Di Franco G, Bastiani L, Furbetta N, Simoncini T, Zirafa C, Melfi F, Buccianti P, Moglia A, Cuschieri A, Mosca F, Morelli L (2018) Robotic colorectal resection with and without the use of the new Da Vinci table motion: a case-matched study. Surg Innov. https://​doi.​org/​10.​1177/​1553350618765540​ CrossRefPubMed
21.
22.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Morelli L, Guadagni S, Lorenzoni V, Di Franco G, Cobuccio L, Palmeri M, Caprili G, D’Isidoro C, Moglia A, Ferrari V, Di Candio G, Mosca F, Turchetti G (2016) Robot-assisted versus laparoscopic rectal resection for cancer in a single surgeon’s experience: a cost analysis covering the initial 50 robotic cases with the da Vinci Si. Int J Colorectal Dis 31:1639–1648. https://doi.org/10.1007/s00384-016-2631-5 CrossRef Morelli L, Guadagni S, Lorenzoni V, Di Franco G, Cobuccio L, Palmeri M, Caprili G, D’Isidoro C, Moglia A, Ferrari V, Di Candio G, Mosca F, Turchetti G (2016) Robot-assisted versus laparoscopic rectal resection for cancer in a single surgeon’s experience: a cost analysis covering the initial 50 robotic cases with the da Vinci Si. Int J Colorectal Dis 31:1639–1648. https://​doi.​org/​10.​1007/​s00384-016-2631-5 CrossRef
26.
30.
Zurück zum Zitat Ramji KM, Cleghorn MC, Josse JM, MacNeill A, O’Brien C, Urbach D, Quereshy FA (2016) Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center. Surg Endosc 30:1337–1343. https://doi.org/10.1007/s00464-015-4390-8 CrossRef Ramji KM, Cleghorn MC, Josse JM, MacNeill A, O’Brien C, Urbach D, Quereshy FA (2016) Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center. Surg Endosc 30:1337–1343. https://​doi.​org/​10.​1007/​s00464-015-4390-8 CrossRef
Metadaten
Titel
Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon’s experience
verfasst von
Luca Morelli
Gregorio Di Franco
Valentina Lorenzoni
Simone Guadagni
Matteo Palmeri
Niccolò Furbetta
Desirée Gianardi
Matteo Bianchini
Giovanni Caprili
Franco Mosca
Giuseppe Turchetti
Alfred Cuschieri
Publikationsdatum
24.09.2018
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 6/2019
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6465-9

Weitere Artikel der Ausgabe 6/2019

Surgical Endoscopy 6/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.